Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statistical tools for setting in-process acceptance criteria.

R J Seely1, L Munyakazi, J Haury

  • 1Corporate QA, Amgen Inc., Longmont, CO 80503, USA. rseely@amgen.com

Developments in Biologicals
|November 19, 2003
PubMed
Summary

Setting appropriate manufacturing process limits is vital. This study presents methods to correct underestimated process variance, enabling more accurate control limits beyond the standard "mean +/- 3 standard deviations" for better process monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current trends in Rwanda's HIV/AIDS epidemic.

Sexually transmitted infections·2006
Same author

The receptor activator of nuclear factor-kappaB ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidism.

Calcified tissue international·2005
Same author

Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis rats.

Cellular and molecular life sciences : CMLS·2000
Same author

The prolonged hematologic effects of a single injection of PEG-rHuMGDF in normal and thrombocytopenic mice.

Experimental hematology·1999
Same author

Systemic effects of pegylated recombinant human megakaryocyte growth and development factor in combination with recombinant murine granulocyte colony-stimulating factor in a murine model of myelosuppression.

Toxicological sciences : an official journal of the Society of Toxicology·1998
Same author

Combined treatment of acute EAE in Lewis rats with TNF-binding protein and interleukin-1 receptor antagonist.

Experimental neurology·1998

Area of Science:

  • Pharmaceutical Manufacturing
  • Process Validation
  • Statistical Quality Control

Background:

  • Meaningful acceptance criteria are essential for process validation and continuous manufacturing monitoring.
  • Current industry standards, like "mean +/- 3 standard deviations," may be inadequate due to underestimated process variance, especially with limited historical data.
  • Artificially constraining limits can lead to misinterpretation of process variability.

Purpose of the Study:

  • To address the challenge of underestimated process variance in setting acceptance criteria.
  • To present statistical methods for correcting variance underestimation.
  • To enable the establishment of more accurate and meaningful control limits for manufacturing processes.

Main Methods:

  • Review of statistical approaches for variance estimation.

Related Experiment Videos

  • Development and presentation of three distinct methods to correct for underestimated process variance.
  • Application of corrected variance estimates to establish acceptance criteria.

    • Main Results:

    • The proposed methods allow for the calculation of acceptance criteria slightly exceeding the standard "mean +/- 3 standard deviations."
    • These adjusted limits better reflect the true process variability.
    • The corrected limits are more effective in identifying deviations caused by specific process issues.

    Conclusions:

    • Accurate variance estimation is critical for robust process validation and monitoring.
    • The presented methods offer a statistically sound approach to refine control limits when variance is underestimated.
    • Implementing these methods enhances the reliability of manufacturing process control and signals true process deviations.